This HTML5 document contains 96 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71159939
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'ochobre de 1965 наукова стаття, опублікована в жовтні 1965 wetenschappelijk artikel scientific article published on 01 October 1965 im Oktober 1965 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q71159939-66E5A508-C9DF-4639-BB2E-AEC6525926E2
wdt:P577
1965-10-01T00:00:00Z
p:P407
wds:Q71159939-4DFC021D-F45B-4F8A-AE80-D7EA440B20C5
wdt:P407
wd:Q1860
p:P2860
wds:Q71159939-92E3532F-846D-42BD-89F6-6667DAA535A2 wds:Q71159939-979A27BE-E1F7-4B24-97A2-3F11806CF9B8 wds:Q71159939-949DFA08-024C-4EDB-A72C-867655CF02AC wds:Q71159939-DAF83FCD-586E-4D03-BC88-2FCF24D155EE wds:Q71159939-BEDDAFBE-27C1-45AB-A570-78864E9117B2 wds:Q71159939-C06F0E62-E373-4C85-94B0-7A96A2DCD8BE wds:Q71159939-F0DA5548-099B-4FA0-A59F-6EDDF729EA3F wds:Q71159939-2EBFF5FA-9721-4A83-B823-058992C96B6D wds:Q71159939-DE713EEE-EC24-456F-BEA9-A1539C753785 wds:Q71159939-3BD44213-EC99-46DA-83A1-7A478665D0F9 wds:Q71159939-81034E97-0F6F-4B1B-BD95-B721047D8A09 wds:Q71159939-77BB29C9-FA38-48DA-A6C7-E41AD8F69BA3 wds:Q71159939-8618A341-CCB6-4066-879A-10704C4B52EE wds:Q71159939-62A83FA5-474D-4F97-AE5B-5306A5E81C32 wds:Q71159939-7129E83E-BB21-4087-B4C7-AE4EC154ADE7 wds:Q71159939-6FF6568D-B306-48EE-A371-A0E2C6A0FE38 wds:Q71159939-0CA1C1A1-7923-44A8-89B6-36DAAA421B75 wds:Q71159939-03BD7BCC-2EA2-4E1A-9501-49F34DE5D158
wdt:P2860
wd:Q79280029 wd:Q78368402 wd:Q79398862 wd:Q79415105 wd:Q64942165 wd:Q79425955 wd:Q76505719 wd:Q76423518 wd:Q79102015 wd:Q75847211 wd:Q79678338 wd:Q79197793 wd:Q78338927 wd:Q78265608 wd:Q78820940 wd:Q76780510 wd:Q75457226 wd:Q73021333
p:P2093
wds:Q71159939-165D2639-0063-42F6-AC60-14B8AFEEC848 wds:Q71159939-14935FB0-D67C-406B-960E-E7B3B408A6EF wds:Q71159939-0BE0B295-6117-4285-BB00-048AE12016EB wds:Q71159939-4044CD75-B9C7-4C96-A9E7-8A83DBEA3B7F wds:Q71159939-243324B6-4F9D-4789-8B2A-4B26472CB972 wds:Q71159939-5C5981AD-4BBF-44F7-9043-6D813A17FA7D wds:Q71159939-4CD39F3E-11A7-4D73-8384-ABD751B0F886 wds:Q71159939-8B65DBD4-9B60-4FEA-B1D1-BF7C11350E40 wds:Q71159939-ACAD2AE2-F4F6-4EAF-96E9-121C44C63B66 wds:Q71159939-9CB44F09-0520-442A-BCA6-9575FC73FAAB wds:Q71159939-D4594538-53F5-47ED-B113-44FD3C069B09 wds:Q71159939-D371EA7F-AD72-4A9C-9C11-2C041A93B666 wds:Q71159939-F2193484-0DD7-4562-9E2F-6D05DAB917B5
wdt:P2093
C E Williamson L E Goodman R L Hirschfeld S P Kramer A Ulfohn D Bakal B Witten S J Abrams S Sass S Calle E H Cendana A M Seligman A B Flores
rdfs:label
Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second
skos:prefLabel
Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second
schema:name
Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second
p:P1476
wds:Q71159939-AABFE157-9B14-42B2-A7D4-4D4AF914DE01
wdt:P1476
Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second
p:P304
wds:Q71159939-F35FD3AA-A423-4AE8-BCB5-20D18A27565B
wdt:P304
663-689
p:P31
wds:Q71159939-523DD045-7777-4D29-A432-3226A6CEE66B
wdt:P31
wd:Q13442814
p:P698
wds:Q71159939-9A11C2C1-1A38-441C-B6E3-C247E9D5B394
wdtn:P698
n11:5319397
wdt:P698
5319397
p:P1433
wds:Q71159939-D05EFA59-2FB5-4B53-AEA9-362EF3248C6A
wdt:P1433
wd:Q4767866
p:P433
wds:Q71159939-84B1F0CE-B7C8-4560-8AD3-9114BDA1C382
p:P478
wds:Q71159939-C837BDE6-ADB6-4088-8ACD-E773EBC6705F
wdt:P433
4
wdt:P478
162
p:P356
wds:Q71159939-B6B4F293-2948-4716-B065-AC00973AEDF4
wdtn:P356
n9:00000658-196510000-00011
wdt:P356
10.1097/00000658-196510000-00011